Oncology & Cancer

Seeing below the skin: Advanced tools to diagnose cancer

(Medical Xpress)—Worried about all the time you spent in the sun during your teen years? There's good reason, says Dr. Jane M. Grant-Kels, chair of the Department of Dermatology at the University of Connecticut Health Center.

Oncology & Cancer

RNA regulator of melanoma could be a new target for cancer therapy

Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online ...

Oncology & Cancer

Adding elesclomol to paclitaxel for advanced melanoma studied

(HealthDay)—Lactate dehydrogenase (LDH) levels may be predictive of success in treating chemotherapy-naive patients with advanced melanoma with a combination of elesclomol plus paclitaxel, according to research published ...

Oncology & Cancer

Researchers study childhood melanoma characteristics

Melanoma, newly diagnosed in more than 76,000 Americans in 2011, is the most common and dangerous form of skin cancer. Melanoma is rare in children, accounting for 1 to 4 percent of all melanoma cases and just 3 percent of ...

page 23 from 39